SOFA Score Calculator
Sequential Organ Failure Assessment — a validated ICU scoring system that quantifies organ dysfunction across six organ systems. Used to track clinical trajectory, estimate mortality risk, and identify sepsis-related organ dysfunction under the Sepsis-3 definitions.
Calculate SOFA Score
Select the worst value for each organ system within the past 24 hours. All six organ systems are required. For a rapid bedside screening tool that does not require laboratory data, see the qSOFA calculator.
The SOFA score is most valuable when trended over time. A single score provides a mortality estimate, but the change in SOFA (delta-SOFA) over the first 48–96 hours of ICU admission is a stronger predictor of outcome. An increase in SOFA ≥ 2 from baseline in the context of suspected infection meets the Sepsis-3 definition of sepsis.
Understanding the SOFA Score
The SOFA score was originally developed in 1996 by a European Society of Intensive Care Medicine (ESICM) consensus conference led by Jean-Louis Vincent. Initially called the Sepsis-related Organ Failure Assessment, it was later renamed the Sequential Organ Failure Assessment to reflect its broader applicability to all critically ill patients — not just those with sepsis.
The score quantifies dysfunction across six organ systems using routine clinical and laboratory data. Each system is scored from 0 (normal function) to 4 (severe dysfunction), producing a total score of 0–24. The key clinical uses are estimating ICU mortality, tracking organ dysfunction trajectory, and — since the 2016 Sepsis-3 definitions — identifying sepsis when an acute increase of ≥ 2 points occurs in the context of suspected infection.
Scoring Structure
6 organ systems, each scored 0–4:
1. Respiration (PaO₂/FiO₂)
2. Coagulation (Platelets)
3. Liver (Bilirubin)
4. Cardiovascular (MAP / vasopressors)
5. CNS (Glasgow Coma Scale)
6. Renal (Creatinine / urine output)
Total range: 0–24 points
Worked Example
A 58-year-old with pneumonia, Day 2 ICU:
PaO₂/FiO₂: 180 on ventilator → 3
Platelets: 95 × 10³ → 2
Bilirubin: 1.8 mg/dL → 1
Cardiovascular: Norepi 0.08 µg/kg/min → 3
GCS: 11 (sedated) → 2
Creatinine: 2.1 mg/dL → 2
SOFA = 13 → High risk. Estimated mortality ~50–60%.
SOFA & Sepsis-3: Under the 2016 Sepsis-3 consensus, sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. This is operationalised as a SOFA score increase of ≥ 2 points from the patient’s baseline. A baseline SOFA of 0 is assumed for patients without known pre-existing organ dysfunction.
Score Interpretation & Mortality Estimates
The SOFA score correlates with ICU mortality in a graded fashion. The mortality estimates below are approximate and derived from large observational cohorts. Actual mortality varies by case mix, institution, and the trajectory of the score over time. A rising SOFA is a stronger predictor of death than any single static value.
| SOFA Score | Severity | Approx. ICU Mortality | Clinical Implication |
|---|---|---|---|
| 0–1 | Minimal dysfunction | < 5% | Routine ICU monitoring; may be suitable for step-down |
| 2–5 | Mild dysfunction | ~5–10% | Active organ support; track for improvement or deterioration |
| 6–9 | Moderate dysfunction | ~15–30% | Escalating support likely needed; reassess goals of care |
| 10–14 | Severe dysfunction | ~40–60% | Multi-organ failure; consider advanced therapies and family discussions |
| 15–24 | Critical dysfunction | > 80% | Profound multi-organ failure; goals-of-care discussion imperative |
The delta-SOFA (change in SOFA over the first 48–96 hours) is more prognostically valuable than the admission SOFA alone. In the landmark Ferreira et al. (2001) study, patients whose SOFA score increased during the first 96 hours of ICU admission had a mortality rate exceeding 50%, regardless of the initial score. Conversely, patients whose SOFA decreased had a mortality under 27%.
Organ System Scoring & Clinical Considerations
Each organ system in the SOFA score uses specific clinical or laboratory parameters with defined thresholds. Understanding the nuances of each component — and the circumstances where scoring is complicated by confounders — is essential for accurate assessment.
The PaO₂/FiO₂ (P/F) ratio is the primary measure of oxygenation efficiency. A P/F ratio below 300 indicates significant impairment (roughly equivalent to ARDS criteria). Scores of 3 and 4 require the patient to be receiving mechanical ventilation or CPAP — without respiratory support, the maximum respiratory score is 2.
Key confounders include FiO₂ estimation on non-invasive oxygen delivery (nasal cannulae, face masks) where the true FiO₂ is imprecise. High-altitude centres may need to adjust for lower ambient PaO₂. The SpO₂/FiO₂ ratio has been proposed as a non-invasive surrogate but is not part of the validated SOFA criteria.
- Score 0: P/F ≥ 400
- Score 1: P/F < 400
- Score 2: P/F < 300
- Score 3: P/F < 200 with respiratory support
- Score 4: P/F < 100 with respiratory support
Thrombocytopenia in critical illness may result from consumption (DIC, sepsis), haemodilution, bone marrow suppression, or drug-induced causes (heparin-induced thrombocytopenia, linezolid). The SOFA coagulation score uses absolute platelet count alone and does not incorporate other coagulation parameters such as INR, fibrinogen, or D-dimer.
In patients with pre-existing thrombocytopenia — such as those with chronic liver disease or haematological malignancy — the baseline platelet count should be documented. A drop from a chronically low baseline (e.g., 80 to 30) is clinically significant even though both values score ≥ 2. Serial platelet trends are more informative than isolated values.
- Score 0: ≥ 150 × 10³/µL
- Score 1: < 150
- Score 2: < 100
- Score 3: < 50
- Score 4: < 20
Total bilirubin is used as a surrogate for hepatic dysfunction. Elevated bilirubin in the ICU setting may result from sepsis-associated cholestasis, ischaemic hepatitis (shock liver), drug-induced liver injury, parenteral nutrition, or pre-existing hepatobiliary disease. It rises relatively late in the course of hepatic insult and may remain elevated for days after the underlying cause has resolved.
Gilbert syndrome — present in approximately 5–10% of the population — causes a mildly elevated unconjugated bilirubin at baseline (typically 1.2–3.0 mg/dL) which may lead to overscoring. Haemolysis from transfusions, mechanical heart valves, or haemolytic anaemias can also elevate bilirubin independently of liver dysfunction.
- Score 0: < 1.2 mg/dL (< 20 µmol/L)
- Score 1: 1.2–1.9 mg/dL (20–32 µmol/L)
- Score 2: 2.0–5.9 mg/dL (33–101 µmol/L)
- Score 3: 6.0–11.9 mg/dL (102–204 µmol/L)
- Score 4: ≥ 12.0 mg/dL (≥ 204 µmol/L)
The cardiovascular component uniquely combines two different types of data: mean arterial pressure (MAP) and vasopressor requirements. Scores 0–1 are based on MAP alone, while scores 2–4 require vasopressor administration at specific doses. The vasopressor doses refer to µg/kg/min for catecholamines (dopamine, dobutamine, epinephrine, norepinephrine).
An important caveat is that vasopressor dosing practices vary between institutions and countries. Some ICUs rarely use dopamine, while others use vasopressin as a first-line adjunct — vasopressin is not included in the original SOFA cardiovascular criteria. Phenylephrine and milrinone are also not represented. This creates scoring inconsistencies depending on local practice patterns.
- Score 0: MAP ≥ 70 mmHg
- Score 1: MAP < 70 mmHg
- Score 2: Dopamine ≤ 5 or dobutamine (any dose)
- Score 3: Dopamine > 5 or epi/norepi ≤ 0.1
- Score 4: Dopamine > 15 or epi/norepi > 0.1
The GCS is the most subjective component of the SOFA score and the most significantly confounded in the ICU setting. Sedation (propofol, midazolam, dexmedetomidine), neuromuscular blockade, and endotracheal intubation all impair the accurate assessment of GCS. The Sepsis-3 authors acknowledged that GCS in sedated patients should ideally be estimated at the last pre-sedation assessment or during a sedation hold.
Patients with pre-existing neurological conditions — stroke with residual deficit, traumatic brain injury, dementia — may have a chronically abnormal GCS that does not reflect acute organ dysfunction. In these cases, document the baseline GCS and score the SOFA CNS component relative to the patient’s known functional status rather than a normative score of 15.
- Score 0: GCS 15
- Score 1: GCS 13–14
- Score 2: GCS 10–12
- Score 3: GCS 6–9
- Score 4: GCS < 6
The renal component uses either serum creatinine or 24-hour urine output — whichever yields the higher (worse) score. Urine output criteria (scores 3 and 4 only) require accurate measurement over a full 24-hour period, which is usually available only in catheterised ICU patients.
Important confounders include patients with chronic kidney disease (CKD) who have an elevated baseline creatinine — these patients may score 2–3 at their usual baseline, making the SOFA renal score less reflective of acute change. Creatinine is also affected by muscle mass: cachectic or elderly patients may have a “normal” creatinine despite significant renal impairment. Patients receiving renal replacement therapy (RRT) present a scoring challenge; many clinicians score the renal component as 4 if the patient requires RRT, though this is not explicitly defined in the original criteria.
- Score 0: Cr < 1.2 mg/dL (< 110 µmol/L)
- Score 1: Cr 1.2–1.9 mg/dL (110–170 µmol/L)
- Score 2: Cr 2.0–3.4 mg/dL (171–299 µmol/L)
- Score 3: Cr 3.5–4.9 mg/dL (300–440 µmol/L) or UO < 500 mL/day
- Score 4: Cr ≥ 5.0 mg/dL (> 440 µmol/L) or UO < 200 mL/day
Special Populations & Considerations
The SOFA score was developed and validated in adult medical and surgical ICU populations. Its performance and interpretation differ in several important subgroups, and clinicians should be aware of these limitations when applying the tool.
Patients with pre-existing CKD may have a baseline creatinine of 3–5 mg/dL, scoring 2–4 on the renal component without any acute change. The SOFA score in these patients overestimates acute organ dysfunction. Use the change from baseline creatinine rather than the absolute value where possible, and document the patient’s pre-admission renal function clearly.
Patients with severe COPD or interstitial lung disease may have a chronically low PaO₂/FiO₂ ratio, and some require home oxygen. A P/F ratio of 280 may be this patient’s norm. As with renal scoring, the clinical question should be whether there has been an acute deterioration from the patient’s baseline respiratory status, not whether the absolute value crosses a threshold.
The standard SOFA score has not been validated in children. Age-specific vital signs, creatinine norms, and GCS modifications are needed. The pSOFA (paediatric SOFA) adapts thresholds for age-appropriate physiology. The 2024 Phoenix Sepsis Score provides an updated paediatric sepsis organ dysfunction tool. Do not apply the adult SOFA to patients under 18 years of age.
Post-cardiac surgery patients frequently have transient haemodynamic instability requiring vasopressors, a low P/F ratio from atelectasis, and thrombocytopenia from heparin and bypass circuits. SOFA scores may be elevated in the immediate post-operative period without indicating true organ failure. Serial assessment over 48–72 hours is more informative than the Day 0 score in surgical populations.
Baseline SOFA: For Sepsis-3 identification, the SOFA increase must be ≥ 2 from baseline. In patients with no known prior organ dysfunction, a baseline SOFA of 0 is assumed. For patients with pre-existing comorbidities (CKD, COPD, cirrhosis), document the estimated baseline SOFA at admission to allow meaningful trending.
Serial SOFA Assessment & Clinical Workflow
The SOFA score achieves its greatest clinical utility when calculated serially over the course of an ICU admission. A single score provides a snapshot of organ dysfunction severity, but the trajectory — improving, static, or worsening — conveys far more prognostic information and should guide clinical decision-making.
Calculate the SOFA score within the first 24 hours of ICU admission using the worst values for each organ system during that period. For patients with pre-existing organ dysfunction (e.g., CKD with baseline Cr 3.0 mg/dL), estimate and document the pre-admission baseline SOFA. This baseline is essential for calculating the delta-SOFA and for applying the Sepsis-3 definition (acute increase ≥ 2).
If the patient was admitted from the emergency department with a qSOFA ≥ 2, the admission SOFA helps confirm or refute the presence of sepsis-related organ dysfunction.
Recalculate the SOFA score every 24 hours using the worst value for each organ system during that period. This captures the peak dysfunction rather than a point-in-time snapshot. Record the sub-scores for each organ individually — this allows identification of which organ systems are improving and which are deteriorating.
Automate where possible: many electronic health record systems can auto-populate SOFA components from flowsheet data (vitals, labs, vasopressor infusions). Manual calculation is error-prone, particularly for the cardiovascular and respiratory components which require interpretation of ventilator settings and infusion rates.
Decreasing SOFA: A declining SOFA score over 48–96 hours is the strongest positive prognostic indicator. Ferreira et al. found that patients with a decreasing SOFA during the first 96 hours had a mortality of approximately 27%, compared to > 50% in those with an increasing or static score. A decrease suggests that therapeutic interventions are effective and organ function is recovering.
Increasing SOFA: A rising SOFA score — even by 1–2 points — should prompt urgent clinical review. Consider whether the underlying diagnosis is correct, whether source control has been achieved, whether antimicrobial therapy is appropriate, and whether additional organ support (mechanical ventilation, renal replacement therapy, vasopressor escalation) is needed.
Static SOFA: A plateau may indicate stabilisation or may precede further deterioration. Continue serial assessment and maintain vigilance for new complications such as hospital-acquired infection, venous thromboembolism, or drug toxicity.
The SOFA trajectory can inform — but should never dictate — goals-of-care conversations with patients and families. A persistently high or rising SOFA score over several days, particularly in the setting of maximal organ support, provides objective data to support discussions about prognosis, treatment escalation limits, and palliative care integration.
Crucially, the SOFA score was developed as a descriptive tool for organ dysfunction, not as a decision-making tool for withdrawal of treatment. No single score threshold should be used as a cutoff for limiting care. Individual patient factors — age, comorbidities, premorbid function, values, and wishes — must always be considered alongside any prognostic score.
Common Pitfalls & Limitations
The SOFA score is one of the most widely used ICU scoring tools, but its apparent simplicity masks several important limitations and sources of error. Awareness of these pitfalls improves the accuracy and clinical utility of the score.
This is the single most common source of SOFA scoring error. The majority of mechanically ventilated ICU patients receive continuous sedation, making accurate GCS assessment impossible. A patient on propofol with a GCS of 6 may have entirely normal neurological function — scoring this as 4 points artificially inflates the total SOFA.
The recommended approach is to use the GCS assessed during a daily sedation hold, or the pre-sedation GCS if a hold is not possible. Some centres assign a GCS of 15 (score 0) to patients on sedation without known neurological pathology, while others use the Richmond Agitation-Sedation Scale (RASS) as a proxy. There is no universally accepted standard, and institutional protocols should be consistent.
The original SOFA cardiovascular criteria only include dopamine, dobutamine, epinephrine, and norepinephrine. Vasopressin — now the most commonly used second-line vasopressor — is not represented. Phenylephrine, milrinone, and levosimendan are also absent. This creates scoring ambiguity: a patient on vasopressin at 0.04 units/min plus norepinephrine at 0.05 µg/kg/min has a degree of cardiovascular compromise that is difficult to map onto the original criteria.
A pragmatic approach is to score based on the catecholamine dose (norepinephrine/epinephrine) and consider vasopressin as additional cardiovascular support that is not captured by the score. This means the SOFA cardiovascular component may underestimate dysfunction in patients receiving vasopressin-based regimens.
Patients with chronic kidney disease, cirrhosis, chronic respiratory failure, or baseline neurological impairment may have elevated SOFA scores at their functional baseline. A patient with CKD stage 4 (Cr 4.0 mg/dL) and COPD (home O₂ with P/F ~250) could score 5–6 on SOFA before any acute illness occurs.
The Sepsis-3 definitions partially address this by requiring a change of ≥ 2 from baseline rather than an absolute threshold. However, establishing the true baseline SOFA requires knowledge of the patient’s pre-admission organ function, which may not be readily available — particularly for patients presenting to the emergency department without prior medical records.
During the COVID-19 pandemic, some crisis standards of care protocols proposed using SOFA scores for triage and resource allocation decisions. This application raised significant ethical concerns: the SOFA score was designed to describe organ dysfunction, not to determine who should receive care. It systematically disadvantages patients with pre-existing organ dysfunction (CKD, cirrhosis) who may still have significant potential for recovery from acute illness.
Professional societies including the American College of Chest Physicians have cautioned against using SOFA as a sole triage criterion. Any resource allocation framework must consider the broader clinical picture, the patient’s acute trajectory, and principles of justice and equity.
The SOFA score requires specific laboratory values (PaO₂, platelets, bilirubin, creatinine) that may not be available at all time points — particularly in resource-limited settings or outside the ICU. Missing values create a dilemma: should they be assumed normal (score 0), carried forward from the last known result, or flagged as incomplete?
The convention is to use the worst value within the 24-hour assessment period. If a value was not measured, the most recent available result is typically carried forward. However, this can mask deterioration (if labs were drawn before a clinical decline) or create artefactual improvement (if a transiently elevated value normalises). Standardising the timing of laboratory draws — e.g., morning panel at a fixed time — can improve scoring consistency.
The SOFA score does not capture gastrointestinal dysfunction (ileus, GI bleeding, intra-abdominal hypertension), endocrine dysfunction (adrenal insufficiency, thyroid storm), or immunological dysfunction (lymphopenia, immunosuppression). These organ systems can contribute significantly to morbidity and mortality in critical illness but are not reflected in the total score.
Quick Reference Summary
scored 0–4 each
Sepsis-3 criteria
SOFA ≥ 15
| Organ System | Parameter | Score 0 | Score 4 (Worst) |
|---|---|---|---|
| Respiration | PaO₂/FiO₂ (mmHg) | ≥ 400 | < 100 + vent |
| Coagulation | Platelets (×10³/µL) | ≥ 150 | < 20 |
| Liver | Bilirubin (mg/dL) | < 1.2 | ≥ 12.0 |
| Cardiovascular | MAP / vasopressors | MAP ≥ 70 | High-dose pressors |
| CNS | Glasgow Coma Scale | 15 | < 6 |
| Renal | Creatinine / UO | < 1.2 mg/dL | ≥ 5.0 or UO < 200 |
The Golden Rule: A single SOFA score estimates severity — but the trend predicts outcome. Always calculate serial SOFA scores and focus on the delta-SOFA over 48–96 hours. A rising SOFA demands urgent clinical reassessment regardless of the absolute value.
Disclaimer & References
For Educational Purposes Only. This calculator and the accompanying clinical information are intended as educational tools for healthcare professionals. They do not replace clinical judgement. Results should be interpreted in the full clinical context. Lab reference ranges vary by institution — verify with your own laboratory. Drug dosages should be confirmed against current prescribing information.
References
- Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22(7):707–710. DOI: 10.1007/BF01709751
- Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. DOI: 10.1001/jama.2016.0287
- Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754–1758. DOI: 10.1001/jama.286.14.1754
- Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762–774. DOI: 10.1001/jama.2016.0288
- Raith EP, Udy AA, Bailey M, et al. Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit. JAMA. 2017;317(3):290–300. DOI: 10.1001/jama.2016.20328
- Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score — development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):374. DOI: 10.1186/s13054-019-2663-7
- de Grooth HJ, Geenen IL, Girbes AR, Vincent JL, Parienti JJ, Oudemans-van Straaten HM. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017;21(1):38. DOI: 10.1186/s13054-017-1609-1
- Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063–e1143. DOI: 10.1097/CCM.0000000000005337
- Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):775–787. DOI: 10.1001/jama.2016.0289
- Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med. 1998;26(11):1793–1800. DOI: 10.1097/00003246-199811000-00016